Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery
Authors:
Open Access
- 19 July 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 112 (3) , 837-842
Abstract
1 The present study was designed to test the hypothesis that beneficial effects of angiotensin converting enzyme (ACE)inhibitors are independent of a fall in blood pressure in rat experimental heart failure following coronary ligation. 2 The animals were assigned randomly to six groups; sham operation, controls subjected to coronary ligation (control), coronary ligation plus chronic treatment with ACE inhibitors at non- and hypotensive doses; perindopril (0.2 or 2 mg kg−1 day−1) or enalapril (2 or 20 mg kg−1 day−1) for three weeks starting one week after the ligation. 3 Systemic blood pressure was measured every week during the experiments. At the end of the treatments, cardiac function and heart weight (an index of myocardial hypertrophy) were determined. In the other animals, ACE activities in plasma and tissues including heart, kidney, lung and blood vessels were measured. 4 In the controls, cardiac ACE activity, weight of right ventricle and left ventricular end-diastolic pressure (LVEDP) were higher compared to those in the sham-operated animals four weeks after the coronary ligation. However, ACE activities were not changed in plasma, kidney, lung and aorta by ligation of the coronary artery. 5 The chronic treatment with perindopril at a dose of 0.2 mg kg−1 day−1 inhibited the increase in ACE activity in cardiac tissue and suppressed the right ventricular hypertrophy without affecting systemic haemodynamics. In contrast, enalapril at a dose of 20 mg kg−1 day−1, but not 2 mg kg−1 day−1, prevented the development of the right ventricular hypertrophy. Enalapril at 20 mg kg−1 day−1 also lowered systemic blood pressure. 6 There is no significant correlation between systemic blood pressure and right ventricular hypertrophy at the end of the treatment with perindopril (r = 0.06) or enalapril (r = 0.1). 7 These findings demonstrate that perindopril, an ACE inhibitor, prevents cardiac hypertrophy without affecting systemic blood pressure in the rat with heart failure after coronary ligation, and suggest that selective augmentation of ACE activity in cardiac tissue is involved in the progression of hypertrophy in this model.Keywords
This publication has 23 references indexed in Scilit:
- Ramiprilat increases bradykinin outflow from isolated hearts of ratBritish Journal of Pharmacology, 1993
- Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.Circulation, 1992
- Beneficial effects of trandolapril on experimentally induced congestive heart failure in ratsThe American Journal of Cardiology, 1992
- A specific B2‐bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramiprilBritish Journal of Pharmacology, 1992
- Kinins mediate the antiproliferative effect of ramipril in rat carotid arteryBiochemical and Biophysical Research Communications, 1992
- Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.Circulation Research, 1991
- Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the ratThe American Journal of Cardiology, 1988
- Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat.Journal of Clinical Investigation, 1986
- Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function.Circulation Research, 1981
- Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.Circulation, 1981